tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
How To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsTrendingPortfolio
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

TNGX Stock Latest News

Tango Therapeutics initiated with a Buy at Jefferies
The FlyTango Therapeutics initiated with a Buy at Jefferies
11d ago
TNGX
Tango Therapeutics price target lowered to $13 from $16 at H.C. Wainwright
PremiumThe Fly
Tango Therapeutics price target lowered to $13 from $16 at H.C. Wainwright
2M ago
TNGX
Tango Therapeutics price target lowered to $14 from $16 at Guggenheim
PremiumThe Fly
Tango Therapeutics price target lowered to $14 from $16 at Guggenheim
2M ago
TNGX
Tango Therapeutics price target lowered to $13 from $18 at Barclays
PremiumThe Fly
Tango Therapeutics price target lowered to $13 from $18 at Barclays
2M ago
TNGX
Medivir licensee Tango Therapeutics discontinues TNG348 clinical program
PremiumThe Fly
Medivir licensee Tango Therapeutics discontinues TNG348 clinical program
2M ago
TNGX
Tango Therapeutics to discontinue development of TNG348 program
PremiumThe FlyTango Therapeutics to discontinue development of TNG348 program
2M ago
TNGX
Tango Therapeutics reports Q1 EPS (35c), consensus (31c)
PremiumThe Fly
Tango Therapeutics reports Q1 EPS (35c), consensus (31c)
3M ago
TNGX
Cantor starts Tango Therapeutics with Overweight on tumor pipeline
PremiumThe Fly
Cantor starts Tango Therapeutics with Overweight on tumor pipeline
4M ago
TNGX
Tango Therapeutics initiated with an Overweight at Cantor Fitzgerald
PremiumThe Fly
Tango Therapeutics initiated with an Overweight at Cantor Fitzgerald
4M ago
TNGX
Tango Therapeutics price target raised to $17 from $16 at H.C. Wainwright
PremiumThe Fly
Tango Therapeutics price target raised to $17 from $16 at H.C. Wainwright
4M ago
TNGX
Navigating the AI Minefield: Tango Therapeutics’ Struggle with Security Risks and EU Regulations
PremiumCompany Announcements
Navigating the AI Minefield: Tango Therapeutics’ Struggle with Security Risks and EU Regulations
4M ago
TNGX
Tango Therapeutics reports Q4 EPS (32c), consensus (28c)
PremiumThe Fly
Tango Therapeutics reports Q4 EPS (32c), consensus (28c)
4M ago
TNGX
Tango Therapeutics to Highlight Preclinical Data on Precision Oncology Pipeline at the American Association for Cancer Research (AACR) Annual Meeting 2024
PremiumPress ReleasesTango Therapeutics to Highlight Preclinical Data on Precision Oncology Pipeline at the American Association for Cancer Research (AACR) Annual Meeting 2024
5M ago
TNGX
Rivian downgraded, Lowe’s upgraded: Wall Street’s top analyst calls
PremiumThe Fly
Rivian downgraded, Lowe’s upgraded: Wall Street’s top analyst calls
6M ago
U
BYD
Tango Therapeutics initiated with an Overweight at Piper Sandler
PremiumThe Fly
Tango Therapeutics initiated with an Overweight at Piper Sandler
6M ago
TNGX
Tango Therapeutics to Present at the Guggenheim Healthcare Talks | 6th Annual Biotechnology Conference
PremiumPress Releases
Tango Therapeutics to Present at the Guggenheim Healthcare Talks | 6th Annual Biotechnology Conference
6M ago
TNGX
Tango Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
PremiumPress Releases
Tango Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
7M ago
TNGX
Tango Therapeutics doses first patient in TNG348 trial
PremiumThe Fly
Tango Therapeutics doses first patient in TNG348 trial
7M ago
TNGX
Tango Therapeutics announces first patient dosed in Phase 1/2 trial of TNG348
PremiumThe Fly
Tango Therapeutics announces first patient dosed in Phase 1/2 trial of TNG348
7M ago
TNGX
Tango Therapeutics initiated with a Buy at B. Riley
PremiumThe FlyTango Therapeutics initiated with a Buy at B. Riley
8M ago
TNGX
Tango Therapeutics initiated with bullish view at B. Riley
PremiumThe Fly
Tango Therapeutics initiated with bullish view at B. Riley
8M ago
TNGX
Tango Therapeutics to present data on PRMT5 inhibitors at SNO meeting
PremiumThe Fly
Tango Therapeutics to present data on PRMT5 inhibitors at SNO meeting
9M ago
TNGX

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >